BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19240070)

  • 1. Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals.
    Bogaerts P; Rodriguez-Villalobos H; Laurent C; Deplano A; Struelens MJ; Glupczynski Y
    J Antimicrob Chemother; 2009 May; 63(5):1073-5. PubMed ID: 19240070
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals.
    Bogaerts P; Rodriguez-Villalobos H; Bauraing C; Deplano A; Laurent C; Berhin C; Struelens MJ; Glupczynski Y
    Pathol Biol (Paris); 2010 Feb; 58(1):78-83. PubMed ID: 19892478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
    Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
    J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital.
    Mammeri H; Eb F; Berkani A; Nordmann P
    J Antimicrob Chemother; 2008 Mar; 61(3):498-503. PubMed ID: 18250231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMY-20, a novel AmpC-type beta-lactamase from South African clinical Escherichia coli isolates.
    Mocktar C; Govinden U; Sturm AW; Essack SY
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):405-8. PubMed ID: 18207348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa.
    Fournier D; Hocquet D; Dehecq B; Cholley P; Plésiat P
    J Antimicrob Chemother; 2010 Feb; 65(2):364-5. PubMed ID: 20008045
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units.
    Baudry PJ; Mataseje L; Zhanel GG; Hoban DJ; Mulvey MR
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):379-83. PubMed ID: 19775846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131.
    Oteo J; Cercenado E; Cuevas O; Bautista V; Delgado-Iribarren A; Orden B; Pérez-Vázquez M; García-Cobos S; Campos J
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):270-6. PubMed ID: 20462723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most Escherichia coli strains overproducing chromosomal AmpC beta-lactamase belong to phylogenetic group A.
    Corvec S; Prodhomme A; Giraudeau C; Dauvergne S; Reynaud A; Caroff N
    J Antimicrob Chemother; 2007 Oct; 60(4):872-6. PubMed ID: 17660264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of boronic acid inhibition with different cephalosporins against Escherichia coli producing AmpC β-lactamases.
    Upadhyay S; Sen MR; Bhattacharjee A
    J Med Microbiol; 2011 May; 60(Pt 5):691-3. PubMed ID: 21292860
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of Escherichia coli clinical isolates producing AmpC plasmidic beta-lactamase during a 5-year period in a French teaching Hospital.
    Corvec S; Crémet L; Leprince C; Dauvergne S; Reynaud A; Lepelletier D; Caroff N
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):277-81. PubMed ID: 20462724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
    Ensor VM; Jamal W; Rotimi VO; Evans JT; Hawkey PM
    Int J Antimicrob Agents; 2009 May; 33(5):487-9. PubMed ID: 19097760
    [No Abstract]   [Full Text] [Related]  

  • 15. New Delhi metallo-beta-lactamase: a cautionary tale.
    Muir A; Weinbren MJ
    J Hosp Infect; 2010 Jul; 75(3):239-40. PubMed ID: 20435372
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of Escherichia coli harbouring extended-spectrum beta-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal.
    Costa D; Poeta P; Sáenz Y; Vinué L; Rojo-Bezares B; Jouini A; Zarazaga M; Rodrigues J; Torres C
    J Antimicrob Chemother; 2006 Dec; 58(6):1311-2. PubMed ID: 17023496
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLST typing of Escherichia coli isolates overproducing AmpC {beta}-lactamase.
    Guillouzouic A; Caroff N; Dauvergne S; Lepelletier D; Perrin Guyomard A; Kempf I; Reynaud A; Corvec S
    J Antimicrob Chemother; 2009 Jun; 63(6):1290-2. PubMed ID: 19307170
    [No Abstract]   [Full Text] [Related]  

  • 19. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
    Mammeri H; Nazic H; Naas T; Poirel L; Léotard S; Nordmann P
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4050-3. PubMed ID: 15388478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan.
    Yu WL; Ko WC; Cheng KC; Chen HE; Lee CC; Chuang YC
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):460-7. PubMed ID: 18455901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.